Hada İlaç
Hada İlaç is a Turkish pharmaceutical manufacturer in Ergene/Tekirdağ that produces hormone and non-hormone drug products in sterile and non-sterile formulations, holding GMP certification and selling exclusively to domestic healthcare professionals and institutions.
- Company typePrivate
- Founded-
- HeadquartersTekirdag
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Hada İlaç does
Hada İlaç San. ve Tic. Ltd. Şti. (operating as Hada Pharma) is a Turkish pharmaceutical manufacturer based in Ergene/Tekirdağ that produces hormone and non-hormone drug products in both sterile and non-sterile formulations. Its operations are anchored at a 6,000 m² facility (3,000 m² enclosed) located within the Vakıflar Organized Industrial Zone in Tekirdağ, and the company holds GMP (Good Manufacturing Practices) certification issued by TITCK following a successful opening inspection in February. The company's product range is organized into hormone products (sterile and non-sterile subcategories) and non-hormone products (sterile subcategory), with no individual SKUs publicly enumerated beyond category structure.
The company sells exclusively to the domestic Turkish market through a B2B model in which access to product information on its website is gated behind healthcare worker verification, indicating sales to physicians, pharmacists, and healthcare institutions via the standard Turkish pharmaceutical distribution network. Distribution is single-country/domestic through wholesalers and direct-to-healthcare-professional channels, with no evidence of export activity or foreign market presence. The firm is privately held with no disclosed investors, parent company, or funding rounds.
Commercial go-to-market relies on enterprise field sales supplemented by trade show participation (Expomed Eurasia Fair 2024), an English-language website version, a LinkedIn corporate page, and a Kariyer.net employer profile for recruitment. A pharmacovigilance partnership with DeltaPV supports post-market adverse-event reporting obligations. No pricing, revenue, production volume, or contract data is publicly disclosed.
Hada İlaç firmographics
Firmographics- Name
- Hada İlaç
- Legal name
- Hada İlaç San. ve Tic. Ltd. Şti.
- Website
- https://hadapharma.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Hada İlaç is a Turkish pharmaceutical manufacturer in Ergene/Tekirdağ that produces hormone and non-hormone drug products in sterile and non-sterile formulations, holding GMP certification and selling exclusively to domestic healthcare professionals and institutions.
- Ownership category
- akta.pro rank
Where Hada İlaç is headquartered
LocationHeadquarters
- HQ city
- Tekirdag
Offices1 record
Markets served
Hada İlaç business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Pharmaceutical Products: Hada İlaç generates revenue through the manufacturing and sale of pharmaceutical products including hormone and non-hormone medications, both sterile and non-sterile formulations. The company obtained GMP certification indicating readiness for commercial pharmaceutical production.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Hada İlaç product offering
Product offeringCore offering
Hada İlaç is a Turkish pharmaceutical manufacturer that produces hormone and non-hormone drug products in both sterile and non-sterile formulations at its GMP-certified Ergene/Tekirdağ production facility. The company sells its pharmaceutical portfolio to healthcare professionals, pharmacies, hospitals, and the Turkish pharmaceutical distribution network, with product access gated behind healthcare worker approval.
Product overview
Hada İlaç is a Turkish pharmaceutical company offering a portfolio of hormone and non-hormone pharmaceutical products. The product range is organized into two main categories: Hormone Products (with Sterile and Non-Sterile subcategories) and Non-Hormone Products (with Sterile subcategory). The products are manufactured at the company's Ergene/Tekirdağ production facility and are available exclusively to healthcare professionals through a health worker approval system.
Differentiator
Problem solved
Functional benefit
Products and services
- Hormone Pharmaceutical Products (Hormon Ürünleri) Hormone-based pharmaceutical products manufactured in sterile and non-sterile formulations at Hada İlaç's GMP-certified Ergene/Tekirdağ facility, available to healthcare professionals (physicians, pharmacists) and institutions in Turkey.
- Non-Hormone Pharmaceutical Products (Non Hormon Ürünleri) Non-hormone pharmaceutical products manufactured in sterile formulations at Hada İlaç's GMP-certified Ergene/Tekirdağ facility, available to healthcare professionals and institutions in Turkey.
Companies that use Hada İlaç
Customer profileSegments1 record
Ideal customer profiles1 record
Hada İlaç technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Hada İlaç partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- DeltaPV (Farmakovijilans Birimi)coreDeltaPV provides pharmacovigilance services for Hada İlaç. Adverse effect reports related to Hada products can be reported via email [email protected] or phone 0216 385 93 33.
Scale indicators2 records
Recent moves4 records
Expansion highlights4 records
Hada İlaç competitors and assessment
Company assessmentEmerging players
- World Medicine İlaç: Growing Turkish pharmaceutical manufacturer with generics and specialty products. Comparable as an emerging domestic pharma manufacturer scaling production capacity and competing for similar healthcare-professional customers.
Direct peers
- Vem İlaç: Turkey-based pharmaceutical manufacturer of generic sterile injectables and other dosage forms. Direct comparable in sterile manufacturing capabilities and target customer segment (hospitals and healthcare institutions).
- Adeka İlaç: Turkish pharmaceutical manufacturer with sterile injectable and specialty product portfolio. Comparable as a domestic Turkish pharma peer competing in similar therapeutic and formulation categories via hospital and pharmacy channels.
- Ali Raif İlaç: Established Turkish pharmaceutical manufacturer with a generics portfolio including sterile formulations. Comparable as a domestic competitor in the same regulatory framework (TİTCK) with overlapping production capabilities.
- Bilim Pharmaceuticals: Turkish pharmaceutical manufacturer producing generic medications across multiple dosage forms. Comparable as a domestic Turkish pharma peer selling through healthcare providers and pharmacies, competing for similar formulary positions.
- Nobel İlaç: Turkish-based pharmaceutical manufacturer with a broad generic and specialty portfolio. Directly comparable in business model — domestic Turkish pharma manufacturer selling through healthcare-professional channels — and overlaps with Hada İlaç in sterile/non-sterile formulation categories.
- Santa Farma: Turkish pharmaceutical manufacturer with branded generics and contract manufacturing operations. Comparable as a Turkish pharma peer with similar B2B distribution model and hormone/specialty therapeutic focus.
Broad incumbents
- Abdi İbrahim: Largest Turkish pharmaceutical manufacturer offering a broad branded generics portfolio across multiple therapeutic areas. Highly comparable as a domestic Turkish pharma producer competing in the same market Hada İlaç is entering, but at vastly greater scale and breadth.
- Sandoz Türkiye: Global generics leader with substantial Turkish operations. Comparable as a manufacturer of sterile and non-sterile generics sold through Turkish healthcare professionals, but at multinational scale and with deeper product breadth.
- Eczacıbaşı İlaç: Diversified Turkish life-sciences group with pharmaceutical manufacturing operations. Comparable as a Turkish-based pharma manufacturer serving domestic healthcare professionals through similar distribution channels.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat2 records
Key risks6 records
Key highlights7 records
Customer concentration
Hada İlaç social profiles
Digital presenceHada İlaç compliance and trust
Trust signalCompliance1 record
Hada İlaç financial estimates
Financial estimateRevenue estimate
Valuation estimate
Hada İlaç leadership team
Management profileNumber of profiles
Profiles4 records
Hada İlaç funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Hada İlaç M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Hada İlaç
What does Hada İlaç do?
Hada İlaç is a Turkish pharmaceutical manufacturer that produces hormone and non-hormone drug products in both sterile and non-sterile formulations at its GMP-certified Ergene/Tekirdağ production facility. The company sells its pharmaceutical portfolio to healthcare professionals, pharmacies, hospitals, and the Turkish pharmaceutical distribution network, with product access gated behind healthcare worker approval.
Is Hada İlaç a public or private company?
Hada İlaç is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Hada İlaç founded?
Hada İlaç was founded in -1. It employs 51 to 100 people.
Where is Hada İlaç based?
Hada İlaç is headquartered in Tekirdag.
How does Hada İlaç make money?
One revenue line is on record: pharmaceutical Products.
Who are Hada İlaç's main competitors?
World Medicine İlaç is listed as an emerging player. Direct peers are Vem İlaç, Adeka İlaç, Ali Raif İlaç, Bilim Pharmaceuticals, Nobel İlaç and Santa Farma. Broad incumbents are Abdi İbrahim, Sandoz Türkiye and Eczacıbaşı İlaç.
Does Hada İlaç have an API?
No public API is recorded for Hada İlaç.